Fulcrum shares plunged to a 52-week low of about $2.90 after the company halted development of its lead sickle cell disease drug, pociredir. ・Heron shares fell to a record low of $0.44 after a federal ...
Fintel reports that on November 12, 2025, D. Boral Capital maintained coverage of MicroVision (NasdaqGM:MVIS) with a Buy recommendation. As of November 8, 2025, the average one-year price target for ...
MicroVision, Inc. (NASDAQ:MVIS) is one of the best lidar stocks to buy right now. On September 4, the company confirmed that Glen W. DeVos will take over as the chief executive officer on September 30 ...
MicroVision provided 2026 revenue guidance: "We expect revenue to be in the range of $10 million to $15 million. This is based on our analysis completed to date of both prior MicroVision outlook going ...